论文部分内容阅读
作者用体外膜肺(ECM)成功救活1名患呼吸道合胞病毒(RSV)性毛细支气管炎的濒死婴儿之后,联系在美国ECMO集中注册的全部医务人员,以收集全国在本病治疗中应用ECMO的经验。方法1988年3月用电话联系参与美国ECMO集中注册中37个中心的医疗主任或临床协作者,请求证实在其中心用ECM0治疗的全部RSV毛细支气管炎婴儿。12例患儿被证实。复查医疗记录,完成本研究所制定的资料基础形式。全部数据均以均数±SD表示,统计学分析用Student t检验完成。结果83～88年期间,37个中心中9个中心共报告12例被治疗的RSV感染患儿。其中,8例(67%)胎龄<
After successful rescue of a dying infants with respiratory syncytial virus (RSV) bronchiolitis by extracorporeal membrane lung (ECM), the authors contacted all medical personnel enrolled centrally in the United States ECMO to collect information on the treatment of this disease in the country Experience with applying ECMO. Methods In March 1988, 37 medical centers or clinical collaborators participating in the centralized US ECMO registration were requested by phone to confirm the presence of all RSV bronchitis babies treated with ECM0 in their centers. Twelve cases were confirmed. Review medical records and complete the data base forms developed in this study. All data are mean ± SD, statistical analysis with Student t test completed. Results During the 83-88 years, 12 of the 37 infants with RSV infection were reported in 9 of 37 centers. Among them, 8 cases (67%) gestational age <